SHAKAIBULLAH SHARIEF: Open Payments
NPI 1316620644 · FLORAL PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,938 in 200 payments from 23 companies in 2025. Trend: 2023 $446 · 2024 $3,628 · 2025 $3,938
Food & beverage: $3,938
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 38 | $710 |
| Janssen Pharmaceuticals, Inc | 13 | $394 |
| ABBVIE INC. | 16 | $367 |
| Alkermes, Inc. | 15 | $282 |
| Corium, LLC | 12 | $221 |
| Supernus Pharmaceuticals, Inc. | 15 | $211 |
| Otsuka America Pharmaceutical, Inc. | 10 | $199 |
| Teva Pharmaceuticals USA, Inc. | 12 | $199 |
| Neurocrine BioSciences, Inc. | 7 | $179 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $171 |
Products named: REXULTI, SPRAVATO, VRAYLAR, ARISTADA, Azstarys, Qelbree, INGREZZA, CAPLYTA.
Industry payments across NY — which companies pay providers there.
